News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
857,337 Results
Type
Article (87180)
Company Profile (705)
Press Release (769428)
Multimedia
Podcasts (162)
Webinars (24)
Section
Business (232953)
Career Advice (4136)
Deals (39778)
Drug Delivery (132)
Drug Development (91184)
Employer Resources (200)
FDA (18240)
Job Trends (17384)
News (397147)
Policy (39886)
Tag
Academia (3002)
Academic (2)
Accelerated approval (17)
Adcomms (33)
Allergies (112)
Alliances (56979)
ALS (134)
Alzheimer's disease (1637)
Antibody-drug conjugate (ADC) (203)
Approvals (18227)
Artificial intelligence (445)
Autoimmune disease (43)
Automation (23)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (145)
Biotechnology (483)
Bladder cancer (115)
Brain cancer (45)
Breast cancer (429)
Cancer (3438)
Cardiovascular disease (297)
Career advice (3550)
Career pathing (36)
CAR-T (224)
CDC (45)
Cell therapy (615)
Cervical cancer (29)
Clinical research (74801)
Collaboration (1247)
Company closure (4)
Compensation (829)
Complete response letters (46)
COVID-19 (2938)
CRISPR (74)
C-suite (474)
Cystic fibrosis (128)
Data (3588)
Decentralized trials (2)
Denatured (58)
Depression (91)
Diabetes (406)
Diagnostics (7031)
Digital health (28)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (211)
Drug pricing (168)
Drug shortages (36)
Duchenne muscular dystrophy (176)
Earnings (98614)
Editorial (52)
Employer branding (25)
Employer resources (169)
Events (132282)
Executive appointments (947)
FDA (20416)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1109)
Gene editing (159)
Generative AI (43)
Gene therapy (488)
GLP-1 (980)
Government (5339)
Grass and pollen (7)
Guidances (330)
Healthcare (20934)
HIV (48)
Huntington's disease (32)
IgA nephropathy (52)
Immunology and inflammation (206)
Immuno-oncology (17)
Indications (44)
Infectious disease (3150)
Inflammatory bowel disease (177)
Inflation Reduction Act (13)
Influenza (84)
Intellectual property (153)
Interviews (814)
IPO (17919)
IRA (59)
Job creations (5195)
Job search strategy (2863)
Kidney cancer (15)
Labor market (67)
Layoffs (619)
Leadership (30)
Legal (10143)
Liver cancer (88)
Longevity (12)
Lung cancer (484)
Lymphoma (247)
Machine learning (18)
Management (65)
Manufacturing (538)
MASH (114)
Medical device (14810)
Medtech (14826)
Mergers & acquisitions (22660)
Metabolic disorders (1043)
Multiple sclerosis (113)
NASH (23)
Neurodegenerative disease (177)
Neuropsychiatric disorders (49)
Neuroscience (2499)
NextGen: Class of 2025 (7687)
Non-profit (5094)
Now hiring (54)
Obesity (525)
Opinion (302)
Ovarian cancer (111)
Pain (147)
Pancreatic cancer (142)
Parkinson's disease (212)
Partnered (27)
Patents (373)
Patient recruitment (243)
Peanut (56)
People (65996)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23063)
Phase II (32476)
Phase III (24453)
Pipeline (2392)
Policy (276)
Postmarket research (3554)
Preclinical (10414)
Press Release (72)
Prostate cancer (168)
Psychedelics (49)
Radiopharmaceuticals (281)
Rare diseases (586)
Real estate (7409)
Recruiting (76)
Regulatory (27606)
Reports (64)
Research institute (2670)
Resumes & cover letters (650)
Rett syndrome (11)
RNA editing (15)
RSV (62)
Schizophrenia (114)
Series A (183)
Series B (135)
Service/supplier (30)
Sickle cell disease (75)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4314)
State (2)
Stomach cancer (17)
Supply chain (90)
Tariffs (81)
The Weekly (102)
Vaccines (997)
Venture capital (63)
Weight loss (362)
Women's health (56)
Worklife (21)
Date
Today (112)
Last 7 days (637)
Last 30 days (2769)
Last 365 days (34111)
2025 (22876)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (76)
Alaska (7)
Arizona (291)
Arkansas (14)
Asia (50750)
Australia (8913)
California (8739)
Canada (2654)
China (812)
Colorado (368)
Connecticut (388)
Delaware (236)
Europe (116535)
Florida (1296)
Georgia (300)
Hawaii (3)
Idaho (67)
Illinois (781)
India (45)
Indiana (422)
Iowa (19)
Japan (261)
Kansas (121)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1201)
Massachusetts (6612)
Michigan (293)
Minnesota (534)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (99)
New Hampshire (75)
New Jersey (2409)
New Mexico (31)
New York (2385)
North Carolina (1339)
North Dakota (10)
Northern California (3882)
Ohio (279)
Oklahoma (18)
Oregon (49)
Pennsylvania (1842)
Puerto Rico (18)
Rhode Island (44)
South America (1654)
South Carolina (45)
South Dakota (1)
Southern California (3296)
Tennessee (141)
Texas (1360)
United States (32548)
Utah (263)
Virginia (237)
Washington D.C. (82)
Washington State (754)
West Virginia (4)
Wisconsin (90)
There are 857,337 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Checkpoint Surgical Marks Milestone with the First Use of Investigational Nerve Regeneration System Regen10® in the FASTR-TEN Clinical Trial
September 5, 2025
·
1 min read
Press Releases
Minimal Residual Disease (MRD) Testing in Solid Tumors: Bridging Clinical Promise, Evidence, and Coverage Realities
September 5, 2025
·
1 min read
Psychedelics
With Lykos MDMA Rejection Letter Out, MAPS Founder Decries ‘Change of the Goal Posts’
Rick Doblin, the founder of the Multidisciplinary Association for Psychedelic Studies, which founded Lykos, bemoaned a “moving of the goal posts” in Lykos’ rejection but looked for positives in the newly released complete response letter.
September 5, 2025
·
3 min read
·
Dan Samorodnitsky
Press Releases
InMed to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
September 5, 2025
·
3 min read
Press Releases
AI Corporate Citizens Require Context: Why Data Orchestration Is Key to Scaling AI in Life Sciences
New thought leadership highlights the foundational role of data orchestration in enabling intelligent automation and Service-as-Software in biopharma.
September 5, 2025
·
1 min read
Government
Senate Hearing Devolves Into Theater as Kennedy Accused of Breaking Vaccine Promises
Robert F. Kennedy Jr. repeated a series of anti-vaccine talking points during his appearance in front of the Senate finance committee on Thursday, as Democratic and Republican senators alike hammered the Health Secretary on recent COVID-19 vaccine restrictions and his views on Operation Warp Speed.
September 5, 2025
·
4 min read
·
Dan Samorodnitsky
Layoff Tracker
AC Immune To Cut 30% of Workforce
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
September 5, 2025
·
196 min read
·
BioSpace Editorial Staff
Events
Advancing Cell + Gene Therapies for Cancer
ASGCT’s “Advancing Cell and Gene Therapies for Cancer” is a 1.5 day conference taking place October 15-16, 2025, at the Philadelphia Marriott Downtown, focusing on the latest research in cell and gene therapies for cancer treatment. Attendees will explore cutting-edge advancements in oncolytic viruses, cell and immunotherapies, and combination approaches designed to improve patient outcomes while tackling critical challenges like tumor heterogeneity and delivery limitations.
September 5, 2025
Government
Monarez Blasts Partisan Public Health Policy at CDC Under RFK Jr.
Ousted CDC Director Susan Monarez claimed in an op-ed published in
The
Wall Street Journal
Thursday that she was fired for refusing to rubber-stamp COVID-19 recommendations to be made by an advisory panel that has expressed “antivaccine rhetoric.”
September 5, 2025
·
2 min read
·
Tristan Manalac
Press Releases
RNA Therapeutics Market Size to Reach USD 26.13 Billion by 2034
September 5, 2025
·
1 min read
1 of 85,734
Next